About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

RECRUITINGNCT06100978

Patient-reported Outcome and Patient-reported Experience After Status Epilepticus

Status epilepticus (SE) is a common life-threatening neurological emergency in which prolonged or multiple closely spaced seizures can result in long-term impairments. SE remains associated with consi...

Lead sponsor: Versailles Hospital•13 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Contacts

Gwenaelle Jacq, RN,MSc,PhDc

CONTACT

33139638356 gjacq@ght78sud.fr

Sponsors

Lead Sponsor

Versailles Hospital

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Adults 18 years old or older
•Patients previously included in the ICTAL registry (Status Epilepticus cohort NCT03457831)
•Survivors after ICU management for Status Epilepticus More than 3 months and less than 5 years after ICU discharge

Exclusion Criteria

•Legal guardianship
•Opposition to participate
•Unread and unwritten French language
•Patient not affiliated to a Social Security system

Related studies

Feasibility of CALM in Patients With Ovarian Cancer

NCT06459271 · Patient Satisfaction, Ovarian Cancer

Hospital at Home Versus Inpatient Care: Costs and Effectiveness

NCT07274072 · Costs and Cost Analysis, Effectiveness, and more

Portable Rapid Imaging for Medical Emergencies

NCT06930534 · Patient Satisfaction, Conventional Magnetic Resonance Imaging, and more

TeamBirth-SWE - a Care Process to Improve Safe and Person-centered Intrapartum Care

NCT06926504 · Person Centered Care, Patient Safety, and more

Infliximab Infusion Rates in Pediatric Inflammatory Bowel Disease

NCT06839820 · Infliximab, Infusion, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 5, 2024Terms

Trial snapshot

StatusRECRUITING

Phase—

Enrollment145

Start dateMay 2024

Last updatedNov 5, 2024

Condition

Patient Reported Outcomes Patient Satisfaction Long Term Outcomes Status Epilepticus Intensive Care Unit+2 more

Locations shown

CH d'Angoulême

Angoulême

CH de Béthune

Béthune

Hôpital Beaujon

Clichy

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 5, 2024Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions